Agilent Technologies Inc. The system is expected to be available, through the Agilent sales network, in April. We are pleased to be working with such a well-respected and innovative company to gain further market penetration with this important product.
Baseline wander and muscle noise are virtually eliminated.
Inc. ACambridge Heart is engaged in the research, development and commercialization of products for the noninvasive diagnosis of cardiac disease. Using innovative technologies, the Company is addressing such key problems in cardiac diagnosis as the identification of those at risk of sudden cardiac arrest and the early detection of coronary artery disease. Cambridge Heart's Safe Harbor Statement Statements made in this news release that are not historical facts include forward-looking statements that involve risks and uncertainties. About Agilent Technologies Agilent Technologies Inc.